Prostate Cancer | Specialty

Provenge Gains Approval From Medicare Panel

March 31st 2011

The federal agency that determines Medicare reimbursements this week proposed to fully cover the cost of Provenge

Dr. Gomella on Jefferson's Multidisciplinary Cancer Center

March 31st 2011

Dr. Dreicer on the Need to Diagnose and Treat Efficiently

March 31st 2011

Dr. Sandler on Clinical Trials for Liase Inhibitors

March 31st 2011

Dr. Dreicer on Newer Prostate Therapy Survival Benefits

March 30th 2011

Robert Dreicer, MD, from the Taussig Cancer Institute, Discusses How New Treatments Have Improved Survival

Dr. Gomella on Current Prostate Screening Procedures

March 30th 2011

In an interview at the 2011 IPCC Meeting in New York, Leonard G. Gomella, MD, from Jefferson Kimmel Cancer Center, discusses prostate cancer screening procedures.

Dr. Dreicer on Prostate Cancer Combination Therapy

March 29th 2011

Robert Dreicer, MD, from the Taussig Cancer Institute, discusses the various treatments that prostate cancer patients may receive in combination.

Dr. Sandler on Candidates for Liase Inhibitor Clinical Trials

March 29th 2011

Howard M. Sandler, MD, MS, from Cedars-Sinai Medical Center, discusses candidates for liase inhibitor clinical trials.

Traditional LHRH Agonists Versus Newer Drugs

March 29th 2011

Howard M. Sandler, MD, MS, from Cedars-Sinai Medical Center, compares the efficacy of the mechanism of action for traditional LHRH agonists to newer androgen deprivation therapies

Dr. Petrylak Explains Prostate Cancer Clinical Trial Difficulties

March 28th 2011

Daniel P. Petrylak, MD, from Columbia University Medical Center Explains the Difficulties Facing During Prostate Cancer Clinical Trials

Imaging for Prostate Cancer Does Not Adhere to National Guidelines

March 23rd 2011

According to a retrospective review of a SEER-Medicare database presented at the ASCO Genitourinary Cancers Symposium

Robotic-Assisted Laparoscopic Radical Prostatectomy Has Steep Learning Curve

March 23rd 2011

Performing robotic-assisted laparoscopic radical prostatectomy (RALP) surgeries at an expert level is not as easy as has been previously assumed

Bicalutamide During and After Radiation Improves Progression-Free Survival in Men With Rising PSA Following Primary Surgery for Prostate Cancer

March 23rd 2011

According to primary results of a phase III randomized, placebocontrolled trial reported at the 2011 ASCO Genitourinary Cancers Symposium

New Prostate Cancer Test Yields Promising Results

March 22nd 2011

A recent clinical study reviewed the surprising results of a new prostate cancer test.

Dutasteride Followed By Watchful Waiting May Delay Cancer Progression in Men With Early Prostate Cancer

March 22nd 2011

Dutasteride, a drug commonly used to treat benign prostatic hyperplasia, may also be useful as part of a "watchful waiting" strategy

Study Presents Preliminary But Impressive Data In Metastatic Castration- Resistant Prostate Cancer

March 21st 2011

cabozantinib (XL184) - a novel wide-spectrum tyrosine kinase inhibitor (TKI) - achieved dramatic results in patients with castration-resistant prostate cancer

Excessive multivitamin consumption may be linked to prostate cancer

March 16th 2011

Though taking multivitamins has been linked to potential health benefits, a new study has found that an excessive consumption of multivitamins may not be beneficial.

Exercise Routine Recommended for Prostate Cancer Survivors

March 14th 2011

Researchers are calling for prostate cancer survivors to incorporate physical activity into their daily routine.

Dr. Alter on 2011 ASCO GU Prostate Cancer Findings

March 14th 2011

Robert S. Alter, M.D. Co-chief, Urologic Oncology, John Theurer Cancer Center, on prostate cancer research that was presented at the 2011 ASCO Genitourinary meeting.

Advisory Panel Discusses Expanded Indication for Avodart

March 9th 2011

The FDA has released briefing documents noting that the 5-alpha reductase inhibitor increases the risk of high-risk prostate cancer.